Sort by:

Baruch EN, Gleber-Netto FO, Nagarajan P, Rao X, Akhter S, Eichwald T, Xie T, Balood M, Adewale A, Naara S, Sathishkumar HN, Islam S, McCarthy W, Mattson BJ, Ferrarotto R, Wong MK, Davies MA, Jindal S, Basu S, Roversi K, Nikpoor AR, Ahmadi M, Ahmadi A, Harwood C, Leigh I, Gong D, Tallón de Lara P, Tao DL, Davidson TM, Ajami NJ, Futreal A, Rai K, Kochat V, Castillo M, Gunaratne P, Goepfert RP, Hernandez SD, Khushalani NI, Wang J, Watowich SS, Calin GA, Migden MR, Yuan M, Liu N, Ye Y, Hwang WL, Vermeer PD, D'Silva NJ, Bunimovich YL, Yaniv D, Burks JK, Gomez J, Dougherty PM, Tsai KY, Allison JP, Sharma P, Wargo JA, Myers JN, Talbot S, Gross ND, Amit M

Cancer-induced nerve injury promotes resistance to anti-PD-1 therapy.
Nature. 2025;646(8084):462-473 - PMID: 40836096 - PMCID: PMC12406299 - DOI: 10.1038/s41586-025-09370-8

Qin T, Mattox AK, Campbell JS, Park JC, Shin KY, Li S, Sadow PM, Faquin WC, Micevic G, Daniels AJ, Haddad R, Garris CS, Pittet MJ, Mempel TR, ONeill A, Sartor MA, Pai SI

Epigenetic therapy sensitizes anti-PD-1 refractory head and neck cancers to immunotherapy rechallenge.
J Clin Invest. 2025;135(6):ePub - PMID: 40091844 - PMCID: PMC11910227 - DOI: 10.1172/JCI181671

Konstantinopoulos PA, Cai M, Lee EK, Krasner C, Campos SM, Liu JF, Horowitz NS, Shea M, Parsons HA, Wright AA, Bouberhan S, Penson RT, Yeku O, Hayes M, Sawyer H, Polak M, Castro CM, Cheng SC, Weipert CM, Matulonis UA

Serial Circulating Tumor DNA Sequencing to Monitor Response and Define Acquired Resistance to Letrozole/Abemaciclib in Endometrial Cancer.
JCO Precis Oncol. 2025;9:e2400882 - PMID: 40209137 - DOI: 10.1200/PO-24-00882

Rami A, Zhong C, Muniz M, Xie W, Khorasanchi A, Gallagher J, Mohammadi S, Fein D, Voter AF, Stoltenberg H, Gopalakrishan D, Yang Y, Ng TSC, Gafita A, Childs DS, Jacene H, Ravi P

Race and Outcomes to [177Lu]Lu-PSMA-617 in Advanced Prostate Cancer.
Cancers (Basel). 2025;17(12):ePub - PMID: 40563610 - PMCID: PMC12191161 - DOI: 10.3390/cancers17121960

Ssedyabane F, Niyonzima N, Ngonzi J, Najjuma JN, Namuli A, Okeny C, Nuwashaba D, Birungi A, Kajabwangu R, Randall TC, Castro CM, Lee H, Tusubira D

Diagnostic Accuracy of Serum P16ink4A and FOX-P3 Concentrations for Detection of Cervical Lesions Among Women Attending a Cervical Cancer Clinic in Western Uganda: A Case-Control Study.
Anal Cell Pathol (Amst). 2025;2025:1931921 - PMID: 40365511 - PMCID: PMC12074841 - DOI: 10.1155/ancp/1931921

Losee M, Kavanaugh M, Liu M, Borges N, Haberman V, Ritzer J, Wolanski A, Bhimaniya S, Choudhury AD, Hyun H, Stoltenberg H, Kilbridge KL, Morgans A, Pomerantz M, Robertson M, Sakellis C, Shah H, Taplin ME, Wei XX, Ng T, Ravi P, Jacene H

Outcome of Subsequent Therapies After 177Lu-Vipivotide Tetraxetan for Metastatic Castrate-Resistant Prostate Cancer: A Tertiary Cancer Center Experience.
Prostate. 2025;85(8):742-748 - PMID: 40103237 - DOI: 10.1002/pros.24880

Kako B, Strand ET, White MM, Carroll C, Seaman K, McCullough S, O'Shea A, Kaiser JA, Stanford L, Esfahani SA, Mahmood U, Heidari P, Ng TSC

Design and implementation of a patient management system for coordination of theranostics care at a major referral center.
Clin Imaging. 2025;129:110673 - PMID: 41265114 - DOI: 10.1016/j.clinimag.2025.110673

Di Ianni E, Jeon J, Hu H, Quintana JM, Lee C, Haidar EA, Mohammadi S, Zargani-Piccardi A, Mahamdeh M, Hernández IC, Ng TSC, Breyne K, Lee H, Breakefield XO, Miller MA

Enhanced mRNA delivery using ultrasound-delivered click reactive anchors.
bioRxiv. 2025;:ePub - PMID: 39975219 - PMCID: PMC11838329 - DOI: 10.1101/2025.01.28.635330
8 CSV